Meta-analysis of the efficacy and safety of Huanglian Wendan Decoction alone or combined with western medicine in treating insomnia caused by phlegm-heat internal disturbance
{"title":"Meta-analysis of the efficacy and safety of Huanglian Wendan Decoction alone or combined with western medicine in treating insomnia caused by phlegm-heat internal disturbance","authors":"Y.A.N.G. Lei , H.E. Liyun , C.H.E.N. Xiao , W.A.N.G. Kaiyue , F.A.N.G. Yongjun , L.I.A.N.G. Zhuang , Y.A.N.G. Zhao","doi":"10.1016/j.dcmed.2022.10.010","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>To evaluate the efficacy and safety of Huanglian Wendan Decoction (黄连温胆汤, HLWDD) alone or combined with western medicine in treating insomnia caused by phlegm-heat internal disturbance in recent 10 years.</p></div><div><h3>Methods</h3><p>The randomized controlled trials of HLWDD alone or combined with western medicine in treating insomnia caused by phlegm-heat internal disturbance from January 1, 2012 to April 1, 2022 were searched in China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), Wanfang Database, China BioMedical Literature Database (CBM), PubMed, Web of Science, Embase, and Cochrane Library databases. After being screening, the included literature was analyzed to evaluate the effective rate, Pittsburgh Sleep Quality Index (PSQI) score, traditional Chinese medicine (TCM) syndrome score, and adverse reactions of HLWDD on insomnia caused by phlegm-heat internal disturbance. The subgroup analyzed the effect of HLWDD after different treatment courses, and compared the therapeutic effects of HLWDD alone and HLWDD combined with western medicine.</p></div><div><h3>Results</h3><p>Twenty-seven randomized controlled trials were finally included, with a total of 2 395 patients. The results of the meta-analysis showed that the curative effect of HLWDD alone or combined with the western medicine group was better than that of the western medicine group [RR = 1.14, 95% CI (1.06, 1.22), <em>P</em> = 0.000]. The PSQI score [SMD = – 0.31, 95% CI (– 0.42, – 0.20), <em>P</em> = 0.000], TCM syndrome score [SMD = – 0.40, 95% CI (– 0.67, – 0.12), <em>P</em> = 0.005], and adverse reaction rate [RR = 0.21, 95% CI (0.15, 0.29), <em>P</em> = 0.000] of HLWDD alone or combined with western medicine group were significantly reduced compared with the western medicine group. The subgroup’s analysis showed that the curative effect of HLWDD alone or combined with western medicine group of 4 weeks treatment course was better than that of the western medicine group [RR = 1.14, 95% CI (1.03, 1.26), <em>P</em> < 0.05]. The TCM syndrome score of HLWDD alone or combined with the western medicine group of 4 weeks treatment course decreased more obviously than that of the western medicine group [SMD = – 0.60, 95% CI (– 0.96, – 0.25), <em>P</em> < 0.05]. There were no significant differences between HLWDD alone or combined with western medicine group and western medicine group with different treatment courses based on PSQI score and adverse reaction rate. Based on the effective rate, the comparison between the HLWDD alone group and the western medicine group [RR = 1.09, 95% CI (1.00, – 1.20) <em>P</em> < 0.05], and between the HLWDD combined with western medicine group and the western medicine group [RR = 1.15, 95% CI (1.03, 1.29), <em>P</em> < 0.05] was the same. PSQI score [SMD = – 0.44, 95% CI (– 0.59, – 0.30), <em>P</em> < 0.05] and TCM syndrome score [SMD = – 1.10, 95% CI (– 1.59, – 0.61), <em>P</em> < 0.05] of HLWDD combined with western medicine group were significantly lower than those of the western medicine group. There were no significant differences of adverse reaction rate between HLWDD alone group [RR = 0.08, 95% CI (0.04, 0.17), <em>P</em> < 0.05] and HLWDD combined with western medicine group [RR = 0.36, 95% CI (0.24, 0.53), <em>P</em> < 0.05].</p></div><div><h3>Conclusion</h3><p>HLWDD alone or combined with western medicine is an effective treatment for insomnia caused by phlegm-heat internal disturbance, which has a high effective rate, significantly reduced PSQI score and TCM syndrome score, and favorable safety. The best course of treatment is 4 weeks.</p></div>","PeriodicalId":33578,"journal":{"name":"Digital Chinese Medicine","volume":"5 3","pages":"Pages 340-352"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S258937772200057X/pdfft?md5=b4037fcab80192ff0f895d592daddcb4&pid=1-s2.0-S258937772200057X-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Digital Chinese Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S258937772200057X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
To evaluate the efficacy and safety of Huanglian Wendan Decoction (黄连温胆汤, HLWDD) alone or combined with western medicine in treating insomnia caused by phlegm-heat internal disturbance in recent 10 years.
Methods
The randomized controlled trials of HLWDD alone or combined with western medicine in treating insomnia caused by phlegm-heat internal disturbance from January 1, 2012 to April 1, 2022 were searched in China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), Wanfang Database, China BioMedical Literature Database (CBM), PubMed, Web of Science, Embase, and Cochrane Library databases. After being screening, the included literature was analyzed to evaluate the effective rate, Pittsburgh Sleep Quality Index (PSQI) score, traditional Chinese medicine (TCM) syndrome score, and adverse reactions of HLWDD on insomnia caused by phlegm-heat internal disturbance. The subgroup analyzed the effect of HLWDD after different treatment courses, and compared the therapeutic effects of HLWDD alone and HLWDD combined with western medicine.
Results
Twenty-seven randomized controlled trials were finally included, with a total of 2 395 patients. The results of the meta-analysis showed that the curative effect of HLWDD alone or combined with the western medicine group was better than that of the western medicine group [RR = 1.14, 95% CI (1.06, 1.22), P = 0.000]. The PSQI score [SMD = – 0.31, 95% CI (– 0.42, – 0.20), P = 0.000], TCM syndrome score [SMD = – 0.40, 95% CI (– 0.67, – 0.12), P = 0.005], and adverse reaction rate [RR = 0.21, 95% CI (0.15, 0.29), P = 0.000] of HLWDD alone or combined with western medicine group were significantly reduced compared with the western medicine group. The subgroup’s analysis showed that the curative effect of HLWDD alone or combined with western medicine group of 4 weeks treatment course was better than that of the western medicine group [RR = 1.14, 95% CI (1.03, 1.26), P < 0.05]. The TCM syndrome score of HLWDD alone or combined with the western medicine group of 4 weeks treatment course decreased more obviously than that of the western medicine group [SMD = – 0.60, 95% CI (– 0.96, – 0.25), P < 0.05]. There were no significant differences between HLWDD alone or combined with western medicine group and western medicine group with different treatment courses based on PSQI score and adverse reaction rate. Based on the effective rate, the comparison between the HLWDD alone group and the western medicine group [RR = 1.09, 95% CI (1.00, – 1.20) P < 0.05], and between the HLWDD combined with western medicine group and the western medicine group [RR = 1.15, 95% CI (1.03, 1.29), P < 0.05] was the same. PSQI score [SMD = – 0.44, 95% CI (– 0.59, – 0.30), P < 0.05] and TCM syndrome score [SMD = – 1.10, 95% CI (– 1.59, – 0.61), P < 0.05] of HLWDD combined with western medicine group were significantly lower than those of the western medicine group. There were no significant differences of adverse reaction rate between HLWDD alone group [RR = 0.08, 95% CI (0.04, 0.17), P < 0.05] and HLWDD combined with western medicine group [RR = 0.36, 95% CI (0.24, 0.53), P < 0.05].
Conclusion
HLWDD alone or combined with western medicine is an effective treatment for insomnia caused by phlegm-heat internal disturbance, which has a high effective rate, significantly reduced PSQI score and TCM syndrome score, and favorable safety. The best course of treatment is 4 weeks.
目的评价近10年来黄连温胆汤单用或联用西药治疗痰热内邪性失眠的疗效和安全性。方法检索2012年1月1日至2022年4月1日中国知网(CNKI)、中国科技期刊库(VIP)、万方数据库、中国生物医学文献库(CBM)、PubMed、Web of Science、Embase、Cochrane Library等数据库中单用或联合西药治疗痰热内乱型失眠的随机对照试验。筛选后,对纳入的文献进行分析,评价其有效率、匹兹堡睡眠质量指数(PSQI)评分、中医证候评分及对痰热内耗型失眠的不良反应。亚组分析不同疗程后高脂泻泻的疗效,比较单用高脂泻泻与西药联用高脂泻泻的疗效。结果最终纳入27项随机对照试验,共纳入患者2 395例。meta分析结果显示,单用或联用西药组患者的疗效均优于西药组[RR = 1.14, 95% CI (1.06, 1.22), P = 0.000]。单用或联用西药组的PSQI评分[SMD = - 0.31, 95% CI (- 0.42, - 0.20), P = 0.000]、中医证候评分[SMD = - 0.40, 95% CI (- 0.67, - 0.12), P = 0.005]、不良反应率[RR = 0.21, 95% CI (0.15, 0.29), P = 0.000]均显著低于西药组。亚组分析显示,单用或联合西药组治疗4周疗效优于西药组[RR = 1.14, 95% CI (1.03, 1.26), P <0.05]。治疗4周后,高肝郁单药组或联合西药组中医证候评分较西药组下降更明显[SMD = - 0.60, 95% CI (- 0.96, - 0.25), P <0.05]。在PSQI评分及不良反应发生率方面,高脂寡糖单用或联用西药组与不同疗程西药组比较差异无统计学意义。基于有效率,单药组与西药组比较[RR = 1.09, 95% CI (1.00, - 1.20) P <差异有统计学意义(RR = 1.15, 95% CI (1.03, 1.29), P <0.05]相同。PSQI评分[SMD = - 0.44, 95% CI (- 0.59, - 0.30), P <0.05]和中医证候评分[SMD = - 1.10, 95% CI (- 1.59, - 0.61), P <[0.05]与西药联合治疗组相比,显著低于西药治疗组。两组患者不良反应发生率差异无统计学意义[RR = 0.08, 95% CI (0.04, 0.17), P <[0.05]和HLWDD联合西药组[RR = 0.36, 95% CI (0.24, 0.53), P <0.05]。结论中西医结合治疗痰热内邪失眠有效,有效率高,显著降低PSQI评分和中医证候评分,且安全性较好。最佳疗程为4周。